Novartis researchers use automation to rapidly identify starting points for new drugs.

Compounds block a protein involved in many cancers by cementing it shut.

Novartis researchers are learning how a novel approach to immunotherapy could help treat cancer.

Researchers from industry and academia will leverage new chemistry to hit difficult drug targets.

The fast-spreading virus can take multiple routes into developing human nerve cells.

Three-dimensional clusters of human neurons could allow scientists to watch neurological diseases develop in the lab.

Novartis researchers want to use the technology to help them design new drugs.

We leave the lab to find out what people know about cell and gene therapy.

A strong background in biological research prepared Daniel Rooks for his role in shaping the early clinical development of new medicines

Novartis team shares results of a massive oncology experiment with the world to accelerate drug discovery.